Endothelial dysfunction: a therapeutic target in bacterial sepsis?

Area of Science:

• Vascular biology
• Sepsis pathophysiology
• Endothelial cell function

Background:

• Endothelial cells are crucial for vascular integrity, hemostasis, and inflammation.
• Excessive endothelial dysfunction in sepsis contributes to organ dysfunction through inflammation, leakage, and coagulation.
• The vascular endothelium is a proposed therapeutic target in sepsis management.

Purpose of the Study:

• To review mechanisms of sepsis-related endothelial dysfunction.
• To discuss potential therapeutic strategies targeting the endothelium.
• To highlight the challenges and future directions for endothelium-driven sepsis treatments.

Main Methods:

• Review of mechanisms including glycocalyx shedding, nitrosative stress, and coagulation factors.
• Discussion of potential therapeutic implications for each mechanism.
• Exploration of challenges in targeting the endothelium due to its dual role in infection control and damage repair.

Main Results:

• Sepsis-induced endothelial dysfunction involves glycocalyx shedding, nitrosative stress, and altered coagulation.
• Therapeutic interventions targeting these mechanisms are under investigation.
• Restoring endothelial function in sepsis presents challenges due to the need for selective targeting.

Conclusions:

• Endothelium-driven treatments for sepsis are a future possibility.
• Personalized medicine approaches using biomarkers are essential for optimizing therapeutic efficacy.
• Theranostics and pathway-specific biomarkers can improve patient outcomes in sepsis.